Brian J Malloy sold $23M of CRS
President and COO at CARPENTER TECHNOLOGY CORP. 75,458 shares at an average of $304.82, traded Dec 9, 2025, filed Dec 11, 2025.
Score components
- +20RolePresident
- +25Trade size$23.0M at market
- +20Share of holdings soldSold 71% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001756183-25-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 9, 2025 | GGift Common Stock | -3,300 | - | - | 75,573 | Dec 11, 2025 |
| Dec 9, 2025 | MOption exercise Common Stock | +5,774 | $39.02 | $225k | 81,347 | Dec 11, 2025 |
| Dec 9, 2025 | MOption exercise Common Stock | +25,168 | $39.02 | $982k | 106,515 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -6,741 | $303.74 | $2.0M | 99,774 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -7,326 | $304.52 | $2.2M | 92,448 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -5,061 | $305.65 | $1.5M | 87,387 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -1,904 | $306.46 | $583k | 85,483 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -980 | $307.68 | $302k | 84,503 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -741 | $308.61 | $229k | 83,762 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -1,089 | $310.20 | $338k | 82,673 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -3,193 | $307.99 | $983k | 79,480 | Dec 11, 2025 |
| Dec 9, 2025 | SOpen-market sale Common Stock | -605 | $308.53 | $187k | 78,875 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Common Stock | +31,813 | $39.02 | $1.2M | 110,688 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Common Stock | +5,505 | $40.43 | $223k | 116,193 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Common Stock | +4,276 | $58.94 | $252k | 120,469 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Common Stock | +2,094 | $44.13 | $92k | 122,563 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -1,600 | $300.25 | $480k | 120,963 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -3,287 | $301.65 | $992k | 117,676 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -5,545 | $302.62 | $1.7M | 112,131 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -5,681 | $303.45 | $1.7M | 106,450 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -6,108 | $304.47 | $1.9M | 100,342 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -11,894 | $305.55 | $3.6M | 88,448 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -9,473 | $306.41 | $2.9M | 78,975 | Dec 11, 2025 |
| Dec 10, 2025 | SOpen-market sale Common Stock | -100 | $307.45 | $31k | 78,875 | Dec 11, 2025 |
| Dec 11, 2025 | MOption exercise Common Stock | +4,130 | $44.13 | $182k | 83,005 | Dec 11, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock | -2,000 | $303.00 | $606k | 81,005 | Dec 11, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock | -2,130 | $304.00 | $648k | 78,875 | Dec 11, 2025 |
| Dec 9, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -5,774 | - | - | 0 | Dec 11, 2025 |
| Dec 9, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -25,168 | - | - | 31,813 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -31,813 | - | - | 0 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -5,505 | - | - | 0 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -4,276 | - | - | 0 | Dec 11, 2025 |
| Dec 10, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -2,094 | - | - | 4,130 | Dec 11, 2025 |
| Dec 11, 2025 | MOption exercise Employee Stock Option (Right to Buy)derivative | -4,130 | - | - | 0 | Dec 11, 2025 |
Related signals
Other insiders at CARPENTER TECHNOLOGY CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | CRSsell CARPENTER TECHNOLOGY CORP | Steven E Karol director | $1.6M 3,275 shares | -2% | |
| 53Moderate | CARPENTER TECHNOLOGY CORP | James D Dee SVP, Gen Counsel & Sec | $6.2M 15,800 shares | -18% | |
| 48Moderate | CARPENTER TECHNOLOGY CORP | Steven E Karol director | $2.5M 6,500 shares | -4% | |
| 65Notable | CARPENTER TECHNOLOGY CORP | Elizabeth A Socci VP, Contr & Ch Acctg Officer | $1.3M 3,900 shares | -29% | |
| 49Moderate | CARPENTER TECHNOLOGY CORP | Ramin Younessi director | $399k 1,300 shares | -31% | |
| 23Weak | CRSsell CARPENTER TECHNOLOGY CORP | Steven E Karol director | $844k 3,433 shares | -2% | |
| 58Moderate | CARPENTER TECHNOLOGY CORP | Tony R Thene President and CEO | $4.7M 19,000 shares | -3% | |
| 43Moderate | CARPENTER TECHNOLOGY CORP | I Martin Inglis director | $1.4M 5,691 shares | -46% | |
| 33Weak | CRSsell CARPENTER TECHNOLOGY CORP | Anastasios John Hart director | $244k 1,000 shares | -100% | |
| 42Moderate | CARPENTER TECHNOLOGY CORP | Colleen Pritchett director | $280k 1,200 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.